Specialty code 1835P2201X · Richmond, CA
NPI
1992405096
Since 2023
Specialty
Specialty code 1835P2201X
Code 1835P2201X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
901 Nevin Ave
Richmond, CA, 94801
Phone (510) 307-1555
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$394K
4,430 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Sharon Cheung prescribed most often to Medicare patients was Atorvastatin Calcium, with 953 prescriptions and refills. In total Sharon Cheung wrote 4,430 Medicare prescriptions that cost $394K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-12-19.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 953 | 3,158 | 376 | $11K |
| Metformin Hcl Generic | 576 | 1,904 | 230 | $7,568 |
| Metformin Hcl Er Metformin Hcl | 401 | 1,323 | 162 | $3,735 |
| Losartan Potassium Generic | 350 | 1,162 | 137 | $5,166 |
| Glipizide Generic | 335 | 1,110 | 143 | $4,793 |
| Jardiance Empagliflozin | 275 | 903 | 117 | $175K |
| Lisinopril Generic | 252 | 831 | 103 | $3,056 |
| Lisinopril-Hydrochlorothiazide Lisinopril/Hydrochlorothiazide | 104 | 340 | 41 | $1,428 |
| Simvastatin Generic | 89 | 297 | 30 | $1,029 |
| Humulin N Insulin Nph Human Isophane | 87 | 259 | 42 | $15K |
| Glipizide Er Glipizide | 86 | 287 | 35 | $2,710 |
| Insulin Glargine-Yfgn Generic | 85 | 256 | 41 | $13K |
| Humulin 70-30 Insulin Nph Hum/Reg Insulin Hm | 84 | 242 | 32 | $26K |
| Pioglitazone Hcl Generic | 71 | 237 | 29 | $889 |
| Humulin R Insulin Regular, Human | 56 | 144 | 23 | $10K |
Brand drugs: 792 claims; generic drugs: 3,436 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Sharon Cheung were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.